Literature DB >> 32345672

Prognostic Significance of Transient Receptor Potential Vanilloid Type 1 (TRPV1) and Phosphatase and Tension Homolog (PTEN) in Epithelial Ovarian Cancer.

Gwan Hee Han1,2, Doo Byung Chay1, Sanghee Nam3, Hanbyoul Cho4,5, Joon-Yong Chung5, Jae-Hoon Kim1.   

Abstract

BACKGROUND: Transient receptor potential vanilloid type 1 (TRPV1) has been studied in human malignancies, but has not been studied in epithelial ovarian cancer (EOC). We, therefore, investigated the significance of TRPV1 and correlation with phosphatase and tension homolog (PTEN) in EOC.
MATERIALS AND METHODS: Immunohistochemical analyses for TRPV1 and PTEN were performed using a tissue microarray. Moreover, the role of TRPV1 in cell growth was assessed in a EOC cell line.
RESULTS: High TRPV1 expression and the combination of high TRPV1 and low PTEN expression were an independent prognostic factor for overall survival and disease-free survival. In vitro results demonstrated that knockdown of TRPV1 was associated with decreased cell viability and colony formation.
CONCLUSION: There is a strong association between TRPV1 and PTEN and the combination of TRPV1 and PTEN is a strong indicator of prognostic predictor in EOC. Copyright
© 2020, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  Epithelial ovarian cancer; PTEN; TRPV1; tumor marker

Year:  2020        PMID: 32345672      PMCID: PMC7259890          DOI: 10.21873/cgp.20191

Source DB:  PubMed          Journal:  Cancer Genomics Proteomics        ISSN: 1109-6535            Impact factor:   4.069


  34 in total

1.  Transient receptor potential vanilloid type 1 (TRPV1) expression changes from normal urothelium to transitional cell carcinoma of human bladder.

Authors:  Massimo Lazzeri; Maria Giuliana Vannucchi; Michele Spinelli; Elisa Bizzoco; Patrizia Beneforti; Damiano Turini; Maria-Simonetta Faussone-Pellegrini
Journal:  Eur Urol       Date:  2005-10       Impact factor: 20.096

2.  miR-1297 Promotes Cell Proliferation of Non-Small Cell Lung Cancer Cells: Involving in PTEN/Akt/Skp2 Signaling Pathway.

Authors:  Wenjin Bu; Tianyou Luo
Journal:  DNA Cell Biol       Date:  2017-09-05       Impact factor: 3.311

3.  Activation of transient receptor potential vanilloid 1 protects the heart against apoptosis in ischemia/reperfusion injury through upregulating the PI3K/Akt signaling pathway.

Authors:  Xiao-Xue Jiang; Guan-Yu Liu; Han Lei; Zuo-Ling Li; Qing-Ping Feng; Wei Huang
Journal:  Int J Mol Med       Date:  2017-12-21       Impact factor: 4.101

4.  Genomic complexity and AKT dependence in serous ovarian cancer.

Authors:  Aphrothiti J Hanrahan; Nikolaus Schultz; Maggie L Westfal; Rita A Sakr; Dilip D Giri; Stefano Scarperi; Manickam Janakiraman; Manickam Janikariman; Narciso Olvera; Ellen V Stevens; Qing-Bai She; Carol Aghajanian; Tari A King; Elisa de Stanchina; David R Spriggs; Adriana Heguy; Barry S Taylor; Chris Sander; Neal Rosen; Douglas A Levine; David B Solit
Journal:  Cancer Discov       Date:  2012-01       Impact factor: 39.397

5.  Ion channel TRPV1-dependent activation of PTP1B suppresses EGFR-associated intestinal tumorigenesis.

Authors:  Petrus R de Jong; Naoki Takahashi; Alexandra R Harris; Jihyung Lee; Samuel Bertin; James Jeffries; Michael Jung; Jen Duong; Amy I Triano; Jongdae Lee; Yaron Niv; David S Herdman; Koji Taniguchi; Chang-Whan Kim; Hui Dong; Lars Eckmann; Stephanie M Stanford; Nunzio Bottini; Maripat Corr; Eyal Raz
Journal:  J Clin Invest       Date:  2014-08-01       Impact factor: 14.808

6.  The activation of transient receptor potential vanilloid receptor subtype 1 by capsaicin without extracellular Ca2+ is involved in the mechanism of distinct substance P release in cultured rat dorsal root ganglion neurons.

Authors:  He-Bin Tang; Yoshihiro Nakata
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-11-23       Impact factor: 3.000

7.  Capsaicin-induced apoptosis of glioma cells is mediated by TRPV1 vanilloid receptor and requires p38 MAPK activation.

Authors:  C Amantini; M Mosca; M Nabissi; R Lucciarini; S Caprodossi; A Arcella; F Giangaspero; G Santoni
Journal:  J Neurochem       Date:  2007-04-17       Impact factor: 5.372

Review 8.  Real-world evidence in the treatment of ovarian cancer.

Authors:  E A Eisenhauer
Journal:  Ann Oncol       Date:  2017-11-01       Impact factor: 32.976

9.  Expression and functionality of TRPV1 in breast cancer cells.

Authors:  Lea V Weber; Klaudia Al-Refae; Gerhard Wölk; Gabriele Bonatz; Janine Altmüller; Christian Becker; Günter Gisselmann; Hanns Hatt
Journal:  Breast Cancer (Dove Med Press)       Date:  2016-12-13

10.  Activation of PTEN by inhibition of TRPV4 suppresses colon cancer development.

Authors:  Xiaoyu Liu; Peng Zhang; Chuanming Xie; Kathy W Y Sham; Simon S M Ng; Yangchao Chen; Christopher H K Cheng
Journal:  Cell Death Dis       Date:  2019-06-12       Impact factor: 8.469

View more
  3 in total

Review 1.  Emerging Roles for Ion Channels in Ovarian Cancer: Pathomechanisms and Pharmacological Treatment.

Authors:  Concetta Altamura; Maria Raffaella Greco; Maria Rosaria Carratù; Rosa Angela Cardone; Jean-François Desaphy
Journal:  Cancers (Basel)       Date:  2021-02-07       Impact factor: 6.639

2.  Role of TRPV1 ion channel in cervical squamous cell carcinoma genesis.

Authors:  Zhenming Wang; Junhong Dong; Wenxiu Tian; Sen Qiao; Hongmei Wang
Journal:  Front Mol Biosci       Date:  2022-08-22

Review 3.  Calcium Entry through TRPV1: A Potential Target for the Regulation of Proliferation and Apoptosis in Cancerous and Healthy Cells.

Authors:  Kevin Zhai; Alena Liskova; Peter Kubatka; Dietrich Büsselberg
Journal:  Int J Mol Sci       Date:  2020-06-11       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.